Share on LinkedInShare on LinkedIn

ARTICLE · 13 MARCH 2013

Court Expands Promotion Of Off-Label Usage In 2012

Fox Rothschild LLP
Fox Rothschild LLP
Contributor
Fox Rothschild LLP

Fox Rothschild LLP

Who We Are With bold growth, Fox Rothschild brings together 1,000 attorneys coast to coast. We...

View firm profile
Explore more from Fox Rothschild LLP

In looking back at 2012, any summary of the year’s developments would be remiss if it did not mention the U.S. v. Caronia case.

United StatesLitigation, Mediation & Arbitration

In looking back at 2012, any summary of the year's developments would be remiss if it did not mention the U.S. v. Caronia case. The 2nd Circuit Court of Appeals vacated defendant's conviction for introducing a misbranded drug into interstate commerce by finding his promotion of off-label drug uses to be "speech" protected by the First Amendment. This holding represents a significant change with regard to promotional activities and legal compliance – although many compliance challenges remain. 

Mr. Caronia was a sales representative for a pharmaceutical manufacturer, and his promotion of unapproved indications of his company's drugs were recorded by the government. He was subsequently charged with, and convicted for, introducing a misbranded drug into interstate commerce. On appeal, Mr. Caronia argued that the misbranding provisions of the Food, Drug and Cosmetic Act prohibited truthful and non-misleading speech. In particular, he argued that he could not be convicted

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from